Literature DB >> 29387926

Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy.

Jolanta Kunikowska1, Królicki Bartosz2, Królicki Leszek3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29387926     DOI： 10.1007/s00259-018-3934-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  (68)Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma.

Authors:  Arun Sasikumar; Ajith Joy; Raviteja Nanabala; M R A Pillai; Boben Thomas; K R Vikraman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-08       Impact factor: 9.236

2.  Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas.

Authors:  Roberto Andres Salas Fragomeni; Joshua R Menke; Matthias Holdhoff; Clare Ferrigno; John Joseph Laterra; Lilja B Solnes; Mehrbod S Javadi; Zsolt Szabo; Martin G Pomper; Steven P Rowe
Journal:  Clin Nucl Med       Date:  2017-10       Impact factor: 7.794

3.  (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.

Authors:  Emre Demirci; Meltem Ocak; Levent Kabasakal; Clemens Decristoforo; Zübeyir Talat; Metin Halaç; Bedii Kanmaz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-23       Impact factor: 9.236

4.  Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme.

Authors:  A Gabriella Wernicke; Mark A Edgar; Ehud Lavi; He Liu; Pamela Salerno; Neil H Bander; Philip H Gutin
Journal:  Arch Pathol Lab Med       Date:  2011-11       Impact factor: 5.534

5.  Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.

Authors:  Natsuko Nomura; Sandra Pastorino; Pengfei Jiang; Gage Lambert; John R Crawford; Marco Gymnopoulos; David Piccioni; Tiffany Juarez; Sandeep C Pingle; Milan Makale; Santosh Kesari
Journal:  Cancer Cell Int       Date:  2014-03-20       Impact factor: 5.722
  5 in total
  13 in total

1.  Targeting VPAC1 Receptors for Imaging Glioblastoma.

Authors:  Sushil K Tripathi; Rhonda Kean; Emily Bongiorno; Douglas C Hooper; Yuan-Yuan Jin; Eric Wickstrom; Peter A McCue; Mathew L Thakur
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

Review 2.  The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.

Authors:  Ilanah J Pruis; Guus A M S van Dongen; Sophie E M Veldhuijzen van Zanten
Journal:  Int J Mol Sci       Date:  2020-02-04       Impact factor: 5.923

Review 3.  Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma.

Authors:  Aurélie Moreau; Olivia Febvey; Thomas Mognetti; Didier Frappaz; David Kryza
Journal:  Front Oncol       Date:  2019-11-01       Impact factor: 6.244

4.  [18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

Authors:  Marina Orevi; Ofer Shamni; Nomi Zalcman; Alexandre Chicheportiche; Anat Mordechai; Samuel Moscovici; Yigal Shoshan; Tal Shahar; Hanna Charbit; Mijal Gutreiman; Iddo Paldor; Eyal Mishani; Alexander Lossos; Iris Lavon
Journal:  Neurooncol Adv       Date:  2021-01-29

5.  Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway.

Authors:  Yang Gao; Hui Zheng; Liangdong Li; Mingtao Feng; Xin Chen; Bin Hao; Zhongwei Lv; Xiaoyan Zhou; Yiqun Cao
Journal:  Front Cell Dev Biol       Date:  2021-03-04

6.  [68 Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma.

Authors:  Jolanta Kunikowska; Bartosz Cieślak; Beata Gierej; Waldemar Patkowski; Leszek Kraj; Marcin Kotulski; Krzysztof Zieniewicz; Leszek Królicki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-03       Impact factor: 9.236

7.  Expression of glutamate carboxypeptidase II in the glial tumor recurrence evaluated in vivo using radionuclide imaging.

Authors:  Jolanta Kunikowska; Rafał Czepczyński; Dariusz Pawlak; Henryk Koziara; Kacper Pełka; Leszek Królicki
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

8.  Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617.

Authors:  Jolanta Kunikowska; Ingeborga Charzyńska; Radosław Kuliński; Dariusz Pawlak; Michał Maurin; Leszek Królicki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-10       Impact factor: 9.236

9.  Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain.

Authors:  Jayendrakishore Tanjore Ramanathan; Suvi Lehtipuro; Harri Sihto; József Tóvári; Lilla Reiniger; Vanda Téglási; Judit Moldvay; Matti Nykter; Hannu Haapasalo; Vadim Le Joncour; Pirjo Laakkonen
Journal:  J Cell Mol Med       Date:  2020-05-11       Impact factor: 5.310

10.  Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas.

Authors:  Francesco Bertagna; Domenico Albano; Elisabetta Cerudelli; Maria Gazzilli; Raffaele Giubbini; Giorgio Treglia
Journal:  Curr Radiopharm       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.